Open access · CC-BY
via OpenAlex
Urolithin A alleviates vascular remodeling through mitochondrial SIRT3-mediated SOD2 deacetylation and antioxidation in hypertensive rats
Min Dai, Yiming Wang, Hong-Ke Dong, Xiaoyu Xu, Jing-Xiao Wang, Guo-Qing Zhu, Fen Zheng
Redox Report · 2026 · ▲ 3 citations
Abstract
OBJECTIVES: Urolithin A (UA) is a natural polyphenolic compound produced by gut bacteria. Vascular remodeling contributes to hypertension, and vascular smooth muscle cells (VSMCs) proliferation and migration are important processes in vascular remodeling. METHODS: VSMCs were obtained from the thoracic aorta of Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). Intraperitoneal injections of UA (50 mg/kg, every 2 days for 4 weeks) were performed in SHR. RESULTS: UA attenuated proliferation and migration, reduced mitochondrial reactive oxygen species (mitoROS) levels, and increased SOD2 activity in VSMCs of SHR, which were prevented by SOD2 knockdown. UA promoted mitochondrial short-length SIRT3 (SL-SIRT3) production and SOD2 deacetylation. SIRT3 inhibitor 3-TYP abolished the effects of UA on SOD2 deacetylation, mitoROS levels and VSMCs proliferation and migration. Repeated intraperitoneal injection of UA every 2 days for 4 weeks attenuated vascular remodeling and hypertension, increased SL-SIRT3 levels and SOD2 activity, and reduced SOD2 acetylation and mitoROS levels in aorta and mesenteric arteries of SHR. CONCLUSION: UA attenuates VSMCs proliferation and migration in SHR by increasing mitochondrial SL-SIRT3 level, and subsequent SOD2 deacetylation and mitoROS reduction in SHR. Long-term administration of UA attenuates vascular remodeling, hypertension and oxidative stress in SHR.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1080/13510002.2026.2622255
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Dai, M., Wang, Y., Dong, H., Xu, X., Wang, J., Zhu, G., & Zheng, F. (2026). Urolithin A alleviates vascular remodeling through mitochondrial SIRT3-mediated SOD2 deacetylation and antioxidation in hypertensive rats. <em>Redox Report</em>. https://doi.org/10.1080/13510002.2026.2622255
Vancouver
Dai M, Wang Y, Dong H, Xu X, Wang J, Zhu G, et al. Urolithin A alleviates vascular remodeling through mitochondrial SIRT3-mediated SOD2 deacetylation and antioxidation in hypertensive rats. Redox Report. 2026. doi:10.1080/13510002.2026.2622255.
BibTeX
@article{min2026Urolit,
title = {Urolithin A alleviates vascular remodeling through mitochondrial SIRT3-mediated SOD2 deacetylation and antioxidation in hypertensive rats},
author = {Min Dai and Yiming Wang and Hong-Ke Dong and Xiaoyu Xu and Jing-Xiao Wang and Guo-Qing Zhu and Fen Zheng},
journal = {Redox Report},
year = {2026},
doi = {10.1080/13510002.2026.2622255},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Redox report : communications in free radical research 2026
Open access · OA
Urolithin A alleviates vascular remodeling through mitochondrial SIRT3-mediated SOD2 deacetylation and antioxidation in hypertensive rats.
International Journal of Molecular Sciences 2015
Open access · CC-BY
Nitric Oxide and Reactive Oxygen Species in the Pathogenesis of Preeclampsia
Hepatology 2014
Preprint · OA
ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis
Journal of Hematology & Oncology 2013
Open access · CC-BY
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
Genes & Development 2012
Preprint · OA
TAp73 depletion accelerates aging through metabolic dysregulation
Cells 2026
Open access · OA